Compare $ACTU vs $KTTA | Chartloom

Compare

$ACTU vs $KTTA

Actuate Therapeutics Inc · Pasithea Therapeutics Corp

ACTU

Actuate Therapeutics Inc

KTTA

Pasithea Therapeutics Corp

Compare $ACTU vs $KTTA

Comparing Actuate Therapeutics Inc and Pasithea Therapeutics Corp

ACTUActuate Therapeutics Inc

KTTAPasithea Therapeutics Corp

ACTUActuate Therapeutics Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-89.9%

52W performance

-91.3%

FCF yield

-135.8%

KTTAPasithea Therapeutics Corp

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

740.5%

YTD performance

-60.7%

52W performance

-43.0%

FCF yield

-113.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACTU

KTTA

Detailed metrics comparison

ACTU

Actuate Therapeutics Inc

KTTA

Pasithea Therapeutics Corp

Market Cap

ACTU$15M

KTTA$16M

Enterprise Value

ACTU$11M

KTTA$-30M

Price

ACTU$0.61

KTTA$0.47

P/E Ratio

ACTUN/A

KTTAN/A

P/S Ratio

ACTU0.00x

KTTA26.84x

EV/Sales

ACTU0.00x

KTTA0.00x

EV/EBITDA

ACTU0.00x

KTTA0.00x

P/B Ratio

ACTU19.88x

KTTA0.32x

P/FCF Ratio

ACTUN/A

KTTAN/A

EV/FCF

ACTU-0.53x

KTTA1.69x

PEG Ratio

ACTUN/A

KTTAN/A

Forward P/E (NTM)

ACTUN/A

KTTAN/A

Forward P/S (NTM)

ACTUN/A

KTTAN/A

Revenue (TTM)

ACTU$0

KTTA$0

Revenue Growth (YoY)

ACTUN/A

KTTA740.5%

Forward Rev Growth

ACTU50.1%

KTTA0.0%

Gross Margin (TTM)

ACTU0.0%

KTTA100.5%

Operating Margin (TTM)

ACTU0.0%

KTTA0.0%

EBITDA Margin (TTM)

ACTU0.0%

KTTA0.0%

Net Margin (TTM)

ACTU0.0%

KTTA0.0%

FCF Margin (TTM)

ACTUN/A

KTTAN/A

Net Income (TTM)

ACTU$-20M

KTTA$-21M

FCF (TTM)

ACTU$-20M

KTTA$-18M

EPS (TTM)

ACTU-$0.86

KTTA-$0.66

ROE (TTM)

ACTU-34618.0%

KTTA-4949.0%

ROA (TTM)

ACTU-17840.0%

KTTA-4681.0%

ROIC (TTM)

ACTU-32397.0%

KTTA-4949.0%

Cash

ACTU$4M

KTTA$46M

Debt

ACTU$405K

KTTA$0

Net Cash/Debt

ACTU$4M

KTTA$46M

Current Ratio (TTM)

ACTU1.25x

KTTA26.25x

Quick Ratio (TTM)

ACTU1.16x

KTTA24.91x

Debt/Equity (TTM)

ACTU0.41x

KTTA0.00x

Debt/Assets (TTM)

ACTU0.0%

KTTA0.0%

Interest Coverage (TTM)

ACTUN/A

KTTAN/A

Net Debt/EBITDA (TTM)

ACTU0.00x

KTTA0.00x

Beta

ACTU1.66

KTTA0.39

52W Performance

ACTU-91.3%

KTTA-43.0%

YTD Performance

ACTU-89.9%

KTTA-60.7%

% from 52W High

ACTU-92.8%

KTTA-77.3%

% from 52W Low

ACTU1.0%

KTTA66.4%

Asset Turnover (TTM)

ACTU0.00x

KTTA0.01x

FCF Yield (TTM)

ACTU-135.8%

KTTA-113.8%

Earnings Yield (TTM)

ACTU-140.1%

KTTA-136.3%

Dividend Yield (TTM)

ACTUN/A

KTTAN/A

Rule of 40

ACTU0.0

KTTA740.5

EV/GP/RG

ACTUN/A

KTTAN/A

Ticker research

View ACTU research View KTTA research

Metric	ACTU Actuate Therapeutics Inc	KTTA Pasithea Therapeutics Corp
Market & Valuation
Market Cap	$15M	$16M
Enterprise Value	$11M	$-30M
Price	$0.61	$0.47
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	26.84x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.88x	0.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.53x	1.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	740.5%
Forward Rev Growth	50.1%	0.0%
Profitability
Gross Margin (TTM)	0.0%	100.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-21M
FCF (TTM)	$-20M	$-18M
EPS (TTM)	-$0.86	-$0.66
ROE (TTM)	-34618.0%	-4949.0%
ROA (TTM)	-17840.0%	-4681.0%
ROIC (TTM)	-32397.0%	-4949.0%
Financial Health
Cash	$4M	$46M
Debt	$405K	$0
Net Cash/Debt	$4M	$46M
Current Ratio (TTM)	1.25x	26.25x
Quick Ratio (TTM)	1.16x	24.91x
Debt/Equity (TTM)	0.41x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.39
52W Performance	-91.3%	-43.0%
YTD Performance	-89.9%	-60.7%
% from 52W High	-92.8%	-77.3%
% from 52W Low	1.0%	66.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-135.8%	-113.8%
Earnings Yield (TTM)	-140.1%	-136.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	740.5
EV/GP/RG	N/A	N/A
Ticker research	View ACTU research	View KTTA research

Valuation

P/S Ratio

ACTU

0.00x

KTTA

26.84x

EV/FCF

ACTU

-0.53x

KTTA

1.69x

Growth & revenue

Revenue Growth TTM

KTTA

740.5%

Forward Revenue Growth

ACTU

50.1%

KTTA

0.0%

Profitability & performance

Gross Margin

KTTA

100.5%

ACTU

0.0%

ROE

KTTA

-4949.0%

ACTU

-34618.0%

FCF Yield %

KTTA

-113.8%

ACTU

-135.8%

52-Week Performance

KTTA

-43.0%

ACTU

-91.3%

Detailed metrics comparison

ACTU

Actuate Therapeutics Inc

KTTA

Pasithea Therapeutics Corp

Market Cap

ACTU$15M

KTTA$16M

Enterprise Value

ACTU$11M

KTTA$-30M

Price

ACTU$0.61

KTTA$0.47

P/E Ratio

ACTUN/A

KTTAN/A

P/S Ratio

ACTU0.00x

KTTA26.84x

EV/Sales

ACTU0.00x

KTTA0.00x

EV/EBITDA

ACTU0.00x

KTTA0.00x

P/B Ratio

ACTU19.88x

KTTA0.32x

P/FCF Ratio

ACTUN/A

KTTAN/A

EV/FCF

ACTU-0.53x

KTTA1.69x

PEG Ratio

ACTUN/A

KTTAN/A

Forward P/E (NTM)

ACTUN/A

KTTAN/A

Forward P/S (NTM)

ACTUN/A

KTTAN/A

Revenue (TTM)

ACTU$0

KTTA$0

Revenue Growth (YoY)

ACTUN/A

KTTA740.5%

Forward Rev Growth

ACTU50.1%

KTTA0.0%

Gross Margin (TTM)

ACTU0.0%

KTTA100.5%

Operating Margin (TTM)

ACTU0.0%

KTTA0.0%

EBITDA Margin (TTM)

ACTU0.0%

KTTA0.0%

Net Margin (TTM)

ACTU0.0%

KTTA0.0%

FCF Margin (TTM)

ACTUN/A

KTTAN/A

Net Income (TTM)

ACTU$-20M

KTTA$-21M

FCF (TTM)

ACTU$-20M

KTTA$-18M

EPS (TTM)

ACTU-$0.86

KTTA-$0.66

ROE (TTM)

ACTU-34618.0%

KTTA-4949.0%

ROA (TTM)

ACTU-17840.0%

KTTA-4681.0%

ROIC (TTM)

ACTU-32397.0%

KTTA-4949.0%

Cash

ACTU$4M

KTTA$46M

Debt

ACTU$405K

KTTA$0

Net Cash/Debt

ACTU$4M

KTTA$46M

Current Ratio (TTM)

ACTU1.25x

KTTA26.25x

Quick Ratio (TTM)

ACTU1.16x

KTTA24.91x

Debt/Equity (TTM)

ACTU0.41x

KTTA0.00x

Debt/Assets (TTM)

ACTU0.0%

KTTA0.0%

Interest Coverage (TTM)

ACTUN/A

KTTAN/A

Net Debt/EBITDA (TTM)

ACTU0.00x

KTTA0.00x

Beta

ACTU1.66

KTTA0.39

52W Performance

ACTU-91.3%

KTTA-43.0%

YTD Performance

ACTU-89.9%

KTTA-60.7%

% from 52W High

ACTU-92.8%

KTTA-77.3%

% from 52W Low

ACTU1.0%

KTTA66.4%

Asset Turnover (TTM)

ACTU0.00x

KTTA0.01x

FCF Yield (TTM)

ACTU-135.8%

KTTA-113.8%

Earnings Yield (TTM)

ACTU-140.1%

KTTA-136.3%

Dividend Yield (TTM)

ACTUN/A

KTTAN/A

Rule of 40

ACTU0.0

KTTA740.5

EV/GP/RG

ACTUN/A

KTTAN/A

Ticker research

View ACTU research View KTTA research

Metric	ACTU Actuate Therapeutics Inc	KTTA Pasithea Therapeutics Corp
Market & Valuation
Market Cap	$15M	$16M
Enterprise Value	$11M	$-30M
Price	$0.61	$0.47
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	26.84x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.88x	0.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.53x	1.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	740.5%
Forward Rev Growth	50.1%	0.0%
Profitability
Gross Margin (TTM)	0.0%	100.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-21M
FCF (TTM)	$-20M	$-18M
EPS (TTM)	-$0.86	-$0.66
ROE (TTM)	-34618.0%	-4949.0%
ROA (TTM)	-17840.0%	-4681.0%
ROIC (TTM)	-32397.0%	-4949.0%
Financial Health
Cash	$4M	$46M
Debt	$405K	$0
Net Cash/Debt	$4M	$46M
Current Ratio (TTM)	1.25x	26.25x
Quick Ratio (TTM)	1.16x	24.91x
Debt/Equity (TTM)	0.41x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.39
52W Performance	-91.3%	-43.0%
YTD Performance	-89.9%	-60.7%
% from 52W High	-92.8%	-77.3%
% from 52W Low	1.0%	66.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-135.8%	-113.8%
Earnings Yield (TTM)	-140.1%	-136.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	740.5
EV/GP/RG	N/A	N/A
Ticker research	View ACTU research	View KTTA research